This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2014.
Company Filing History:
1 out of 834,453 Years Active: 2014
Title: Martin Fugère: Innovator in Cancer Treatment
Introduction
Martin Fugère is a notable inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing effective methods for inhibiting cancer cell proliferation and tumor growth.
Latest Patents
Fugère holds a patent for "Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents." This patent discloses PACE4 inhibitors, compositions comprising these inhibitors, and their applications in lowering PACE4 activity. The methods outlined in the patent aim to reduce cell proliferation, tumor growth, and metastasis formation, ultimately contributing to cancer prevention and treatment.
Career Highlights
Throughout his career, Martin Fugère has worked with various organizations, including Socpra Sciences Sante Et Humaines S.e.c. His innovative approach to cancer research has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Fugère has collaborated with notable professionals in his field, including Witold A Neugebauer and Robert Day. These partnerships have further enhanced his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Martin Fugère's contributions to cancer research through his patent and collaborations highlight his commitment to improving treatment options for patients. His innovative work continues to pave the way for advancements in the medical field.